GILD – Gilead Sciences, Inc.
(47 Total) [click headers to sort columns]
| Symbol: | GILD |
| Last: | 33.32 |
| Date: | 7/30/2010 |
| Time: | 4:00pm |
| Change: | -0.09 |
| Open: | 33.30 |
| High: | 33.69 |
| Low: | 33.09 |
| Volume: | 10,965,087 |
| Date | RT | Stock | Group | Price | EPS | Sales (M) | Earnings % Chg | Sales % Chg | Earnings Rank | Strength Rank | PES | Avg Vol |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/21/10 | E | GILD – Gilead Sciences, Inc. | MEBB | 33.00 | .85/.69 | 1927 | +23.2- | +17- | 9.8 | 0.9 | 39 | 15,685,000 |
| 04/21/10 | E | GILD – Gilead Sciences, Inc. | MEBB | 45.07 | .99/.66 | 2086 | +50.0+ | +36- | 9.8 | 1.3 | 46 | 10,079,000 |
| 01/27/10 | E | GILD – Gilead Sciences, Inc. | MEBB | 44.87 | .93/.63 | 2032 | +47.6+ | +42+ | 9.9 | 1.7 | 48 | 7,912,000 |
| 10/21/09 | E | GILD – Gilead Sciences, Inc. | MEBB | 46.12 | .78/.55 | 1801 | +41.8- | +31+ | 9.9 | 1.3 | 59 | 6,974,000 |
| 07/22/09 | E | GILD – Gilead Sciences, Inc. | MEBB | 48.55 | .69/.48 | 1647 | +43.8+ | +29+ | 9.8 | 4.7 | 70 | 8,093,000 |
| 04/22/09 | E | GILD – Gilead Sciences, Inc. | MEBB | 43.73 | .66/.53 | 1531 | +24.5- | +22- | 9.7 | 5.7 | 66 | 9,812,000 |
| 01/28/09 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 48.23 | .59/.44 | 1428 | +34.1+ | +30+ | 9.0 | 8.9 | 82 | 9,162,000 |
| 10/17/08 | E | GILD – Gilead Sciences, Inc. | MEBB | 41.39 | .55/.45 | 1371 | +22.2+ | +30+ | 8.8 | 7.7 | 75 | 10,887,000 |
| 07/18/08 | E | GILD – Gilead Sciences, Inc. | MEBB | 55.40 | .49/.46 | 1278 | +6.5- | +22- | 8.9 | 9.3 | 113 | 7,446,000 |
| 04/17/08 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 51.80 | .54/.46 | 1258 | +17.4+ | +22+ | 9.0 | 9.2 | 96 | 9,829,000 |
| 01/24/08 | E | GILD – Gilead Sciences, Inc. | MEBB | 44.81 | .44/.41 | 1095 | +7.3- | +22- | 9.6 | 9.2 | 102 | 7,697,000 |
| 10/19/07 | E | GILD – Gilead Sciences, Inc. | MEBB | 43.51 | .45/.34 | 1059 | +32.4- | +41- | 9.8 | 7.8 | 97 | 7,825,000 |
| 07/20/07 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 40.42 | .46/.31 | 1048 | +48.4- | +53+ | 9.8 | 6.5 | 88 | 7,670,000 |
| 05/08/07 | SS | GILD – Gilead Sciences, Inc. | MEBB | 82.82 | 9.8 | 8.3 | 0 | 4,346,000 | ||||
| 04/19/07 | EX2 | GILD – Gilead Sciences, Inc. | MEBB | 78.43 | .93/.59 | 1028 | +57.6+ | +48+ | 9.8 | 7.7 | 84 | 4,510,000 |
| 02/01/07 | E | GILD – Gilead Sciences, Inc. | MEBB | 64.32 | .83/.54 | 899 | +53.7- | +48- | 9.8 | 3.8 | 77 | 3,659,000 |
| 10/19/06 | EX2 | GILD – Gilead Sciences, Inc. | MEBB | 67.72 | .72/.38 | 749 | +89.5+ | +52+ | 9.8 | 7.7 | 94 | 3,950,000 |
| 07/21/06 | E | GILD – Gilead Sciences, Inc. | MEBB | 59.35 | .61/.41 | 685 | +48.8- | +38- | 9.9 | 7.7 | 97 | 5,465,000 |
| 04/19/06 | E | GILD – Gilead Sciences, Inc. | MEBB | 61.84 | .59/.34 | 693 | +73.5- | +61- | 9.9 | 7.8 | 105 | 3,715,000 |
| 01/31/06 | EX2 | GILD – Gilead Sciences, Inc. | MEBB | 57.90 | .54/.25 | 609 | +116+ | +65+ | 9.8 | 8.6 | 107 | 4,627,000 |
| 10/19/05 | E | GILD – Gilead Sciences, Inc. | MEBB | 48.23 | .38/.25 | 493 | +52- | +51- | 9.8 | 8.7 | 127 | 3,636,000 |
| 07/20/05 | EX2 | GILD – Gilead Sciences, Inc. | MEBB | 46.60 | .41/.24 | 495 | +70.8+ | +55+ | 5.9 | 8.7 | 114 | 3,979,000 |
| 04/20/05 | E | GILD – Gilead Sciences, Inc. | MEBB | 36.19 | .34/.22 | 430 | +54.5+ | +39- | 5.7 | 7.2 | 106 | 384,900 |
| 01/28/05 | E | GILD – Gilead Sciences, Inc. | MEBB | 32.59 | .24/.21 | 370 | +14.3- | +40- | 5.6 | 3.9 | 136 | 3,937,000 |
| 10/22/04 | EX2 | GILD – Gilead Sciences, Inc. | MEBB | 36.68 | .25/.14 | 326 | +78.6+ | +63+ | 5.2 | 8.4 | 147 | 5,747,000 |
| 07/30/04 | E | GILD – Gilead Sciences, Inc. | MEBB | 59.50 | .48/.46 | 320 | +4.3- | +34- | 8.0 | 5.5 | 124 | 3,216,000 |
| 07/28/04 | SS | GILD – Gilead Sciences, Inc. | MEBB | 58.25 | 5.2 | 6.8 | 0 | 3,216,000 | ||||
| 04/23/04 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 59.22 | .45/.24 | 309 | +87.5- | +87+ | 7.7 | 2.3 | 132 | 3,185,000 |
| 01/30/04 | EX2 | GILD – Gilead Sciences, Inc. | MEBB | 60.69 | .42/.17 | 264 | +147+ | +82+ | 7.8 | 5.0 | 145 | 3,642,000 |
| 10/30/03 | E | GILD – Gilead Sciences, Inc. | MEBB | 52.00 | .28/.18 | 200.4 | +55.6- | +49.5- | 7.9 | 3.0 | 186 | 4,228,000 |
| 08/01/03 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 68.23 | .50/.10 | 238.8 | +400 | +118+ | 8.1 | 8.9 | 136 | 3,738,000 |
| 04/24/03 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 45.65 | .25/-.02 | 165.1 | +111+ | 8.0 | 9.1 | 183 | 3,791,000 | |
| 01/31/03 | E | gild – Gilead Sciences, Inc. | MEBB | 36.64 | .18/.69 | 145.0 | -74 | +95- | 8.0 | 8.1 | 204 | 3,791,000 |
| 11/01/02 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 34.74 | .11/-.13 | 133.9 | +163+ | 7.0 | 8.3 | 316 | 3,791,000 | |
| 07/26/02 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 29.05 | .10/-.17 | 109.3 | +116+ | 7.2 | 6.4 | 291 | 4,606,000 | |
| 05/01/02 | E | GILD – Gilead Sciences, Inc. | MEBB | 31.12 | -.02/-.12 | 78.4 | +36- | 0.9 | 4.9 | -1556 | 2,735,000 | |
| 02/01/02 | EX1 | gild – Gilead Sciences, Inc. | MEBB | 65.41 | -.24/-.20 | 74.3 | +42+ | 0.6 | 8.5 | -273 | 2,091,000 | |
| 01/30/02 | SS | GILD – Gilead Sciences, Inc. | MEBB | 67.00 | 1.0 | 8.6 | 0 | 2,067,000 | ||||
| 10/26/01 | EX1 | gild – Gilead Sciences, Inc. | MEBB | 68.80 | -.26/-.19d | 50.9 | +13+ | 0.3 | 9.6 | -265 | 2,362,000 | |
| 07/27/01 | E | gild – Gilead Sciences, Inc. | MEBB | 54.74 | -.34/-.04 | 50.6 | +1- | 0.4 | 8.9 | -161 | 1,795,000 | |
| 04/27/01 | EX1 | gild – Gilead Sciences, Inc. | MEBB | 41.69 | -.24/-.04 | 57.8 | +21+ | 0.8 | 8.8 | -174 | 1,390,000 | |
| 01/29/01 | E | gild – Gilead Sciences, Inc. | MEBB | 64.37 | -.39/-.20 | +8 | 1.6 | 4.4 | -165 | 1,087,000 | ||
| 01/11/01 | SS | GILD – Gilead Sciences, Inc. | MEBB | 89.56 | 2.8 | 3.2 | 0 | 1,062,000 | ||||
| 10/27/00 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 91.00 | -.38/-.70 | 45.2 | +17 | 5.3 | 9.2 | -239 | 709,000 | |
| 07/28/00 | E | GILD – Gilead Sciences, Inc. | MEBB | 67.31 | -.09/-.28 | 50.1 | +15- | 4.9 | 7.8 | -748 | 546,000 | |
| 04/28/00 | EX1 | GILD – Gilead Sciences, Inc. | MEBB | 43.43 | -.13/-.37 | 47.7 | +18 | 3.1 | 2.4 | -334 | 902,000 | |
| 02/01/00 | E | GILD – Gilead Sciences, Inc. | MEBB | 46.81 | -.20/-.45 | +15 | 2.4 | 3.8 | -234 | 1,063,000 | ||
| Date | RT | Stock | Group | Price | EPS | Sales (M) | Earnings % Chg | Sales % Chg | ER | SR | PES | Avg Vol |